Founding Collection · Open
Artificial intelligence across the drug-discovery pipeline.
JAIDD publishes generative molecular design, protein-structure prediction, ADMET modelling and machine-learning methods across the drug-discovery pipeline — from target identification to lead optimisation.
Founding Collection — full APC waiver. Priority editorial handling with a target median of 35 days to first decision, an optional, author-approved graphical abstract in the journal style, and front-page visibility. How to take part →
For the founding phase, manuscripts and expressions of interest may be submitted by email to jaidd@vallensis.org. Full portal submission is available on request.
For the founding phase, manuscripts and expressions of interest may be submitted by email to jaidd@vallensis.org. Full portal submission is available on request.
In scope
Generative DesignAlphaFoldADMET PredictionRetrosynthesisTarget ID
Technical Integrity StandardEvery manuscript passes automated checks before peer review.Founding Editorial BoardWe are assembling the founding board. Interested?Vallensis PublishingSwitzerland-based open-access publisher for biomedical AI.
This journal publishes on a continuous basis — articles appear online immediately upon acceptance, without waiting for issue or volume compilation.
